Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUNG-NEPA: Dexamethasone-sparing regimens with Akynzeo for CINV in NSCLC
NCT04201769Phase 3Unknown
- Sponsor
- Consorzio Oncotech
- Start
- Nov 2016
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
A Phase 3 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Consorzio Oncotech. Status: unknown.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04201769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201769.